Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Share :

European Forum on Oncology 2012

3 Dec 2011
Le Plaza, Brussels, Belgium

The Institute of Cancer Policy

Prof Richard Sullivan – Kings College, London, UK
The Institute of Cancer Policy ( Prof Richard Sullivan – Kings College, London, UK )
23 May 2012

The OECI and EurocanPlatform

Prof Wim van Harten – The Netherlands Cancer Institute, Amsterdam
The OECI and EurocanPlatform ( Prof Wim van Harten – The Netherlands Cancer Institute, Amsterdam )
21 May 2012

Problems in the structure of clinical trials

Prof Thomas Tursz – Institut Gustave Roussy, Paris, France
Problems in the structure of clinical trials ( Prof Thomas Tursz – Institut Gustave Roussy, Paris, France )
21 May 2012

Transfer of information through EurocanPlatform

Prof Ulrik Ringborg – Karolinska Institute, Stockholm, Sweden
Transfer of information through EurocanPlatform ( Prof Ulrik Ringborg – Karolinska Institute, Stockholm, Sweden )
21 May 2012

Prognostic biomarkers and next generation genomic sequencing

Prof Stefan Pfister – Cancer Research Centre, Heidelberg, Germany
Prognostic biomarkers and next generation genomic sequencing ( Prof Stefan Pfister – Cancer Research Centre, Heidelberg, Germany )
21 May 2012

Primary and secondary resistance in colorectal cancer

Dr Silvia Marsoni – The Institute for Cancer Research, Candiolo, Italy
Primary and secondary resistance in colorectal cancer ( Dr Silvia Marsoni – The Institute for Cancer Research, Candiolo, Italy )
21 May 2012

Analysing changes in the pharmaceutical industry

Dr Siegfried Bialojan – Ernst and Young, Germany
Analysing changes in the pharmaceutical industry ( Dr Siegfried Bialojan – Ernst and Young, Germany  )
21 May 2012

Economics of treating patients

Dr Richard Schilsky – University of Chicago, USA
Economics of treating patients ( Dr Richard Schilsky – University of Chicago, USA )
21 May 2012

Heterogeneity of global cancer outcomes

Prof Reinhard Busse – Technische Universitat, Berlin, Germany
Heterogeneity of global cancer outcomes ( Prof Reinhard Busse – Technische Universitat, Berlin, Germany )
18 May 2012

Use of bio-banks in the EurocanPlatform

Prof Peter Riegman – Erasmus Medical Centre, Rotterdam, Netherlands
Use of bio-banks in the EurocanPlatform ( Prof Peter Riegman – Erasmus Medical Centre, Rotterdam, Netherlands )
18 May 2012

Progress of the EurocanPlatform, one year on

Prof Julio Celis – Danish Cancer Center, Copenhagen, Denmark
Progress of the EurocanPlatform, one year on ( Prof Julio Celis – Danish Cancer Center, Copenhagen, Denmark )
18 May 2012

Update on the FP7 TRANSCAN Project

Dr Maria Ferrantini – Istituto Superiore di Sanita, Rome, Italy
Update on the FP7 TRANSCAN Project ( Dr Maria Ferrantini – Istituto Superiore di Sanita, Rome, Italy )
18 May 2012

New approaches to personalised medicine

Prof Jens Ricke – Otto-Von-Guericke-University, Magdeburg, Germany
New approaches to personalised medicine ( Prof Jens Ricke – Otto-Von-Guericke-University, Magdeburg, Germany )
18 May 2012

Bringing together the resources of Eastern and Western European institutes

Prof Ioana Neagoe – Institute of Oncology ‘Prof Dr Ion Chiricuta’, Cluj-Napoca, Romania
Bringing together the resources of Eastern and Western European institutes ( Prof Ioana Neagoe – Institute of Oncology ‘Prof Dr Ion Chiricuta’, Cluj-Napoca, Romania )
18 May 2012

Goals of the German Consortium for Translational Cancer Research

Dr Hubert Serve – University of Frankfurt, Germany
Goals of the German Consortium for Translational Cancer Research ( Dr Hubert Serve – University of Frankfurt, Germany )
18 May 2012

Innovation in molecular imaging

Prof Hedvig Hricak – Memorial Sloan-Kettering Cancer Center, USA
Innovation in molecular imaging ( Prof Hedvig Hricak – Memorial Sloan-Kettering Cancer Center, USA )
16 May 2012

Advances in radiation oncology

Prof Guy Storme – University of Brussels, Belgium
Advances in radiation oncology (  Prof Guy Storme – University of Brussels, Belgium  )
16 May 2012

EurocanPlatform and the exchange of information

Dr Ged Brady – The Paterson Institute for Cancer Research, Manchester, UK
EurocanPlatform and the exchange of information ( Dr Ged Brady – The Paterson Institute for Cancer Research, Manchester, UK )
16 May 2012

Effects of lifestyle change in cancer patients

Prof Cornelia Ulrich – National Center for Tumor Diseases, Heidelberg, Germany
Effects of lifestyle change in cancer patients ( Prof Cornelia Ulrich – National Center for Tumor Diseases, Heidelberg, Germany )
16 May 2012

Benefits of open European research area

Prof Claudio Lombardo – Organisation of European Cancer Institutes
Benefits of open European research area  ( Prof Claudio Lombardo – Organisation of European Cancer Institutes )
16 May 2012

Improving educational events and courses

Prof Angelo Paradiso – Giovanni Paolo II National Cancer Institute, Bari, Italy
Improving educational events and courses ( Prof Angelo Paradiso – Giovanni Paolo II National Cancer Institute, Bari, Italy )
16 May 2012

EurocanPlatform project update

Prof Anton Berns – The Netherlands Cancer Institute, Amsterdam
EurocanPlatform project update ( Prof Anton Berns – The Netherlands Cancer Institute, Amsterdam  )
16 May 2012